EDGAR Filing Documents for 0001470930-16-000002

Form D - Notice of Exempt Offering of Securities:

SEC Accession No. 0001470930-16-000002

Filing Date

2016-09-21

Accepted

2016-09-21 13:12:32

Documents

Effectiveness Date

2016-09-21

Items

Item 06b:

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	D
1		primary_doc.xml	D	8562
	Complete submission text file	0001470930-16-000002.txt		9611

Mailing Address 750 ALFRED NOBEL DRIVE SUITE 106 HERCULES CA 94547

Business Address 750 ALFRED NOBEL DRIVE SUITE 106 HERCULES CA 94547 510 724 1548

BIOXINESS PHARMACEUTICALS, INC. (Filer) CIK: 0001470930 (see all company filings)